Indian Pioglitazone Exporters: Complete Supplier Ranking with Market Share — 115 Manufacturers (2026) — TransData Nexus

Q: Who is the largest pioglitazone supplier from India?

AUROBINDO PHARMA LTD is the largest pioglitazone exporter from India with a 40.7% market share and export value of $15.2M.

Q: How many pioglitazone suppliers are there in India?

There are 115 active pioglitazone exporters in India, collectively shipping $37.3M worth of pioglitazone across 2,674 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top pioglitazone suppliers from India?

The top 5 pioglitazone suppliers from India — AUROBINDO PHARMA LTD, AUROBINDO PHARMA LIMITED, INTAS PHARMACEUTICALS LIMITED, MACLEODS PHARMACEUTICALS LTD, AJANTA PHARMA LIMITED — together control 74.2% of total pioglitazone export value from India.

Suresh Sormare

Pioglitazone

India Pharmaceutical Trade Intelligence

$37.3M115 Suppliers70 CountriesHS 30049099

ExportsIndia → UNITED STATES60.5%India → PHILIPPINES7.8%

ImportsUNITED STATES → India$30.6K BRAZIL → India$4.5K

#1 Buyer: RISING PHARMA

Pioglitazone Suppliers from India (2026) — 115 Exporters, $37.3M Market | TransData Nexus | TransData Nexus

Who Exports Pioglitazone from India — 115 Suppliers Behind a $37.3M Market

India's pioglitazone export market is supplied by 115 active exporters who collectively shipped $37.3M across 2,674 shipments. AUROBINDO PHARMA LTD leads with a 40.7% market share, followed by AUROBINDO PHARMA LIMITED and INTAS PHARMACEUTICALS LIMITED. The top 5 suppliers together control 74.2% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Pioglitazone Suppliers & Exporters — 115 manufacturers, $37.3M export market, top destinations and formulations — Pioglitazone supplier data — 115 exporters · $37.3M market · 2,674 shipmentsTransData Nexus · Indian Customs Data

Top Pioglitazone Exporters from India — Ranked by Export Value

AUROBINDO PHARMA LTD is the leading pioglitazone exporter from India, holding a 40.7% share of the $37.3M market across 2,674 shipments from 115 exporters. The top 5 suppliers — AUROBINDO PHARMA LTD, AUROBINDO PHARMA LIMITED, INTAS PHARMACEUTICALS LIMITED, MACLEODS PHARMACEUTICALS LTD, AJANTA PHARMA LIMITED — collectively control 74.2% of total export value, indicating a highly concentrated market. Individual shares are: AUROBINDO PHARMA LTD (40.7%), AUROBINDO PHARMA LIMITED (10.8%), INTAS PHARMACEUTICALS LIMITED (9.1%), MACLEODS PHARMACEUTICALS LTD (8.9%), AJANTA PHARMA LIMITED (4.7%).

Top Pioglitazone Exporters from India

Ranked by export value · 115 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Pioglitazone Exporters from India — Ranked by Export Value. 115 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Pioglitazone exporters

Certification and compliance status for top Pioglitazone suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Aurobindo Pharma Limited	Approved	Yes (September 2023)	Yes	Multiple	WHO GMP approval for Unit IV in September 2023; FDA warning letter issued in Jun
Intas Pharmaceuticals Limited	Approved	Yes	Yes	Multiple	FDA warning letter in December 2022 for Sanand facility due to data falsificatio
Ajanta Pharma Limited	Approved	Yes	Yes	Multiple	Operates US FDA-approved facilities; no FDA warning letters reported.
Torrent Pharmaceuticals Limited	Approved	Yes	Yes	Multiple	FDA warning letter in May 2011; subsequent compliance achieved.
Micro Labs Limited	Approved	Yes	Yes	Multiple	Operates GMP-compliant facilities; no FDA warning letters reported.
Dr. Reddy's Laboratories Ltd	Approved	Yes	Yes	Multiple	FDA warning letter in November 2019; subsequent compliance achieved.
Cipla Limited	Approved	Yes	Yes	Multiple	Operates US FDA-approved facilities; no FDA warning letters reported.
Macleods Pharmaceuticals Limited	Approved	Yes	Yes	Multiple	Operates US FDA-approved facilities; no FDA warning letters reported.
Mylan Laboratories Limited	Approved	Yes	Yes	Multiple	FDA warning letter in November 2019; subsequent compliance achieved.
Ind-Swift Limited	Approved	Yes	Yes	Multiple	Operates US FDA-approved facilities; no FDA warning letters reported.

TransData Nexus reviewed the regulatory standing of 10 leading Pioglitazone exporters from India. 10 hold US FDA facility approvals, 10 maintain WHO-GMP certification, and 10 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Pioglitazone sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," hosts numerous pharmaceutical companies specializing in active pharmaceutical ingredients (APIs). Aurobindo Pharma Limited, headquartered in Hyderabad, operates multiple manufacturing facilities in the region, producing a wide range of APIs and formulations. Their facilities have received approvals from major regulatory bodies, including the US FDA and UK MHRA.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations industry. Intas Pharmaceuticals Limited, based in Ahmedabad, operates several manufacturing facilities in the area, focusing on formulations across various therapeutic segments. Their facilities are approved by international regulatory agencies such as the US FDA and EMA.

3Mumbai-Thane-Raigad — Export Gateway

The Mumbai-Thane-Raigad belt serves as a crucial export gateway for pharmaceutical products. Macleods Pharmaceuticals Ltd, with operations in this region, contributes significantly to pharmaceutical exports. Their manufacturing units are equipped to produce a diverse range of formulations, catering to both domestic and international markets.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Pioglitazone exporters from India

January 1, 2026

M&A

Aurobindo Pharma Limited — Aurobindo Pharma acquires Khandelwal Labs' non-oncology prescription business for ₹325 crore

Aurobindo Pharma, through its wholly owned subsidiary Auro Pharma Limited, acquired the non-oncology prescription business of Mumbai-based Khandelwal Laboratories Pvt Ltd for ₹325 crore. The acquisition includes 23 established brands across 67 stock-keeping units in pain management and anti-infective segments, supported by a field force of approximately 470 personnel and a distribution network of over 1,600 stockists across India. IMPACT: This acquisition is expected to strengthen Aurobindo Pharma's domestic market presence, potentially enhancing its Pioglitazone export capabilities.

Impact: This acquisition is expected to strengthen Aurobindo Pharma's domestic market presence, potentially enhancing its Pioglitazone export capabilities.

November 25, 2024

Collaboration

Aurobindo Pharma USA Inc. — Aurobindo Pharma USA enters collaboration for respiratory product development

Aurobindo Pharma's wholly owned subsidiary, Aurobindo Pharma USA Inc., entered into a collaboration and license agreement with a global pharmaceutical company for the development and commercialization of specific products in the respiratory therapeutic area. The agreement includes a cost-sharing arrangement with an overall cap of $90 million for Aurobindo over the development period. IMPACT: While focused on respiratory products, this collaboration may indirectly benefit Aurobindo's overall export strategy, including Pioglitazone.

Common Questions — Pioglitazone Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which pioglitazone supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, AUROBINDO PHARMA LTD leads with 547 recorded shipments worth $15.2M. AUROBINDO PHARMA LIMITED (161 shipments) and INTAS PHARMACEUTICALS LIMITED (473 shipments) are also established high-volume exporters.

Q How many pioglitazone manufacturers are there in India?

India has 115 active pioglitazone exporters with a combined export market of $37.3M across 2,674 shipments to 70 countries. The top 5 suppliers hold 74.2% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for pioglitazone from India?

Average FOB unit price: $0.91 per unit, ranging from $0.00 to $78.88. Average shipment value: $13.9K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Pioglitazone

Pioglitazone

Who Exports Pioglitazone from India — 115 Suppliers Behind a $37.3M Market

Top Pioglitazone Exporters from India — Ranked by Export Value

Top Pioglitazone Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Aurobindo Pharma Limited — Aurobindo Pharma acquires Khandelwal Labs' non-oncology prescription business for ₹325 crore

Aurobindo Pharma USA Inc. — Aurobindo Pharma USA enters collaboration for respiratory product development

Common Questions — Pioglitazone Suppliers from India

Q Which pioglitazone supplier from India is the most reliable for bulk orders?

Q How many pioglitazone manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for pioglitazone from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Aurobindo Pharma Limited — Aurobindo Pharma to acquire Lannett Company for $250 million

Analysis Methodology